Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous platelet-rich plasma treatment in Behçet disease
RBR-22z3jyPhase 2Completed
- Sponsor
- Universidade Estadual de Campinas
- Start
- Feb 2014
- Modality
- Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous platelet-rich plasma in Behçet's disease (BD), sponsored by Universidade Estadual de Campinas. Started Feb 2014; status: completed.
02
Drugs
autologous platelet-rich plasma
03
Conditions
Behçet's disease (BD)
Beyond the preview
Go deeper on RBR-22z3jy.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-22z3jy.